Eupraxia Pharmaceuticals Inc
(EPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,316 | 35,908 | 19,342 | 0 | 0 |
| Receivables | 155 | 167 | 191 | 0 | 0 |
| TOTAL | $24,525 | $36,216 | $19,803 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 347 | 382 | 410 | N/A | N/A |
| Other Non-Current Assets | 103 | 39 | 54 | 0 | 0 |
| TOTAL | $450 | $420 | $463 | $N/A | $N/A |
| Total Assets | $24,975 | $36,636 | $20,266 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,554 | 9,520 | 10,399 | 0 | 0 |
| Accounts payable and accrued liabilities | 6,978 | 8,972 | 8,922 | 0 | 0 |
| TOTAL | $11,603 | $18,529 | $19,374 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 57 | 114 | 380 | 175 | 129 |
| TOTAL | $35 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $11,638 | $18,529 | $19,374 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 35,623 | N/A | N/A | N/A |
| Common Shares | 116,318 | 116,318 | 92,914 | 0 | 0 |
| Retained earnings | -117,552 | -111,544 | -105,501 | 0 | 0 |
| Other shareholders' equity | -4,414 | -4,177 | -4,031 | 0 | 0 |
| TOTAL | $13,338 | $18,107 | $892 | $0 | $0 |
| Total Liabilities And Equity | $24,975 | $36,636 | $20,266 | $0 | $0 |